ArticleRadiology case reports2026
The role of multimodal imaging in diagnosis in the diagnosis of epididymal metastasis from prostate carcinoma: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer is a common malignancy in men, typically metastasizing to bones, lymph nodes, and visceral organs. Epididymal metastasis, however, is extremely rare, with a reported prevalence of less than 4% and usually identified incidentally. We report the case of a 72-year-old male with a history of high-risk prostate adenocarcinoma previously treated with radical prostatectomy. During follow-up, the patient presented with a painless right scrotal nodule and a concurrent rise in serum PSA levels. Scrotal ultrasound and contrast-enhanced ultrasound (CEUS) revealed a solid, hypervascularized lesion in the right epididymis. PSMA PET-CT confirmed intense radiotracer uptake at the same site, consistent with metastatic disease. No other distant metastases were detected. The patient was treated with hormonal therapy and monitored through imaging and PSA levels, showing partial response. This case underscores the importance of considering atypical metastatic sites in prostate cancer follow-up. Multimodal imaging, especially CEUS and PSMA PET-CT, plays a pivotal role in the detection and characterization of rare metastatic localizations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.